We are live on
!
Find out more
ECP
Elk Creek Partners Portfolio holdings
AUM
$582M
1-Year Est. Return
10.23%
This Fund
S&P 500
This Quarter
Est. Return
-3.28%
1 Year Est. Return
-10.23%
3 Year Est. Return
+16.39%
5 Year Est. Return
+41.52%
10 Year Est. Return
–
AUM
$1.16B
AUM Growth
-$175M
(-13%)
Cap. Flow
-$71.1M
Cap. Flow
% of AUM
-6.11%
Top 10 Holdings %
Top 10 Hldgs %
23.85%
Holding
127
New
3
Increased
41
Reduced
72
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$16.6M |
| 2 |
Karyopharm Therapeutics
KPTI
|
+$11.5M |
| 3 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$10.8M |
| 4 |
Ligand Pharmaceuticals
LGND
|
+$10.1M |
| 5 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
+$8.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WAGE
WageWorks, Inc.
WAGE
|
+$21M |
| 2 |
MDCO
Medicines Co
MDCO
|
+$13.7M |
| 3 |
MasTec
MTZ
|
+$13.5M |
| 4 |
EFII
Electronics for Imaging
EFII
|
+$13.2M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$12.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.95% |
| 2 | Technology | 17.01% |
| 3 | Industrials | 12.32% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Communication Services | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INXN
1
DELISTED
Interxion Holding N.V.
INXN
| $39.4M | 3.39% |
483,878
-142,540
| -23% | -$11.1M |
|
|
QUOT
2
DELISTED
Quotient Technology Inc
QUOT
| $37.4M | 3.21% |
4,778,256
+625,679
| +15% | +$5.65M |
|
3
Cerus
CERS
$431M
| $35.3M | 3.03% |
6,842,893
+1,902
| +0% | +$10.2K |
|
|
4
Ligand Pharmaceuticals
LGND
$5.76B
| $34M | 2.92% |
547,511
+161,012
| +42% | +$10.1M |
|
|
SNCR
5
DELISTED
Synchronoss Technologies
SNCR
| $28.2M | 2.42% |
579,624
+102,778
| +22% | +$6.97M |
|
|
IVC
6
DELISTED
Invacare Corporation
IVC
| $23.2M | 1.99% |
3,088,239
-461,213
| -13% | -$2.59M |
|
|
INFN
7
DELISTED
Infinera Corporation Common Stock
INFN
| $22M | 1.89% |
4,030,496
-122,722
| -3% | -$539K |
|
8
OneSpan
OSPN
$574M
| $19.8M | 1.7% |
1,362,403
+24,470
| +2% | +$354K |
|
9
Gogo Inc
GOGO
$565M
| $19.5M | 1.68% |
3,231,370
-401,614
| -11% | -$1.89M |
|
10
MaxLinear
MXL
$6.06B
| $18.8M | 1.62% |
841,700
-57,145
| -6% | -$1.27M |
|
11
Iridium Communications
IRDM
$5.02B
| $17.6M | 1.51% |
826,640
+62,343
| +8% | +$1.49M |
|
12
Pacira BioSciences
PCRX
$1.04B
| $17.4M | 1.5% |
457,637
-42,432
| -8% | -$1.69M |
|
13
Evolent Health
EVH
$348M
| $16.4M | 1.41% |
2,284,332
+115,522
| +5% | +$829K |
|
14
Healthcare Services Group
HCSG
$1.6B
| $16.1M | 1.38% |
662,635
+35,302
| +6% | +$891K |
|
|
CVSA
15
Covista Inc
CVSA
$4.25B
| $15.8M | 1.36% |
414,252
+35,131
| +9% | +$1.58M |
|
16
Churchill Downs
CHDN
$5.88B
| $15.3M | 1.32% |
248,624
-23,572
| -9% | -$1.42M |
|
|
NGHC
17
DELISTED
National General Holdings Corp
NGHC
| $14.5M | 1.25% |
631,089
-46,791
| -7% | -$1.1M |
|
18
Essent Group
ESNT
$6.08B
| $14.4M | 1.24% |
301,696
-20,526
| -6% | -$982K |
|
|
LMNX
19
DELISTED
Luminex Corp
LMNX
| $14.4M | 1.24% |
695,718
+43,213
| +7% | +$900K |
|
|
PLYA
20
DELISTED
Playa Hotels & Resorts
PLYA
| $14.3M | 1.23% |
1,831,153
+631,729
| +53% | +$4.84M |
|
|
TVTY
21
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $13.9M | 1.19% |
832,980
-13,203
| -2% | -$228K |
|
|
WMGI
22
DELISTED
Wright Medical Group Inc
WMGI
| $13.8M | 1.19% |
669,807
+25,096
| +4% | +$597K |
|
|
STMP
23
DELISTED
Stamps.com, Inc.
STMP
| $13.5M | 1.16% |
180,667
+5,087
| +3% | +$299K |
|
|
VCRA
24
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $12.8M | 1.1% |
517,780
+170,621
| +49% | +$4.43M |
|
|
CASA
25
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $12.6M | 1.09% |
1,607,800
-109,069
| -6% | -$732K |
|
Similar funds
BAC
AVC
OWD
PP
WWM
JA
PL
EA
Elk Creek Partners's Q3 2019 Portfolio in Review
As of Q3 2019, Elk Creek Partners held 127 positions worth $1.16B, down 13% from $1.34B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Elk Creek Partners withdrew a net $71.1M in Q3 2019, closing 11 positions and reducing 72 holdings. Its most notable exit was WageWorks, Inc., an estimated $21M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.
Against the trend, Elk Creek Partners opened a new position in Karyopharm Therapeutics worth $12.2M.
- Elk Creek Partners's largest Q3 2019 buy was Karyopharm Therapeutics: 84,715 shares worth $12.2M.
- Elk Creek Partners added most to Clovis Oncology, Inc. in Q3 2019, an estimated $16.6M increase.
- Elk Creek Partners's biggest Q3 2019 reduction was MasTec, cutting an estimated $13.5M.
- Elk Creek Partners fully exited WageWorks, Inc. in Q3 2019, selling an estimated $21M.
- Elk Creek Partners's ten largest holdings make up 24% of its $1.16B portfolio in Q3 2019.
- Elk Creek Partners opened 3 new positions and closed 11 in Q3 2019.
- Elk Creek Partners's portfolio value fell 13% quarter-over-quarter to $1.16B.
Based on Elk Creek Partners's 13F filing for Q3 2019, filed 13 Nov 2019.